BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15120099)

  • 1. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A; Calzetti S
    Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement disorders and depression due to flunarizine and cinnarizine.
    Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
    Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
    Negrotti A; Calzetti S; Sasso E
    Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinnarizine-induced parkinsonism: ten years later.
    Martí-Massó JF; Poza JJ
    Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
    Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
    BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
    [No Abstract]   [Full Text] [Related]  

  • 8. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
    Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
    Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF; Poza JJ
    Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-induced parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
    Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
    Veitch K; Hue L
    Mol Pharmacol; 1994 Jan; 45(1):158-63. PubMed ID: 8302275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between structure and drug-induced parkinsonism.
    Sawada Y; Nasu R; Matsuo H; Ohtani H
    Ann Pharmacother; 2000 May; 34(5):668. PubMed ID: 10852100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinson disease induced by flunarizine].
    de Sá PN; Heinisch LM
    Arq Neuropsiquiatr; 1989 Dec; 47(4):471-3. PubMed ID: 2634389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.
    Chouza C; Scaramelli A; Caamaño JL; De Medina O; Aljanati R; Romero S
    Lancet; 1986 Jun; 1(8493):1303-4. PubMed ID: 2872433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Akathisia, parkinsonism and depression induced by cinnarizine: a case report].
    Stucchi-Portocarrero S; Vega-Dienstmaier JM; Saavedra JE; Sagástegui A
    Rev Neurol; 1999 May 1-15; 28(9):876-8. PubMed ID: 10390751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
    Fabiani G; Pastro PC; Froehner C
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of parkinsonism in a Brazilian movement disorders clinic.
    Cardoso F; Camargos ST; Silva Júnior GA
    Arq Neuropsiquiatr; 1998 Jun; 56(2):171-5. PubMed ID: 9698723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles.
    Terland O; Flatmark T
    Neuropharmacology; 1999 Jun; 38(6):879-82. PubMed ID: 10465691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.